Overview
- 57 inspections across 56 sites are on record.
- 69 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-19.
At a glance
Inspections
57
Sites
56
Observations
69
Career since
May 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nowcos Co., Ltd. | 19 Jun 2026 | Human Drugs | View 483 → |
| Cosmecca Korea Co., Ltd. | 2 Jun 2026 | Human Drugs | |
| BPI Labs, LLC | 17 Apr 2026 | Human Drugs | View 483 → |
| American Regent, Inc. | 5 Mar 2026 | Human Drugs | View 483 → |
| KP Pharmaceutical Technology | 13 Feb 2026 | Human Drugs |
Sites inspected
Nowcos Co., Ltd.Sejong, Korea (the Republic of)1 insp.
Cosmecca Korea Co., Ltd.Eumseong, Korea (the Republic of)1 insp.
BPI Labs, LLCLargo, United States1 insp.
American Regent, Inc.Columbus, United States1 insp.
KP Pharmaceutical TechnologyBloomington, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Wen Ning Chan9 shared
Lauren N Howard3 shared
Robert J Ham2 shared
Anna M Spiros2 shared
WenNing Chan2 shared
Tiara M Brown2 shared
Charles L Zhou2 shared
John D Mcintosh1 shared
Pamela N Agaba1 shared
Megan T Ziegler1 shared
Full investigator report
Get the verbatim findings behind Lisa R Hilliard's 69 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site